Approximately 360 million euros of investments in the three ports of the Network, already completed works and new interventions to be planned through an integrated vision of infrastructure, energy and ...

In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...